Literature DB >> 27598473

Chronic Respiratory Symptoms with Normal Spirometry. A Reliable Clinical Entity?

Roberto Rodriguez-Roisin1, MeiLan K Han2, Jørgen Vestbo3, Jadwiga A Wedzicha4, Prescott G Woodruff5, Fernando J Martinez6.   

Abstract

Mesh：

Year:  2017        PMID： 27598473     DOI： 10.1164/rccm.201607-1376PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  19 in total

Review 1.  Defining Impaired Respiratory Health. A Paradigm Shift for Pulmonary Medicine.

Authors:  Paul A Reyfman; George R Washko; Mark T Dransfield; Avrum Spira; MeiLan K Han; Ravi Kalhan
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

2.  Update in Chronic Obstructive Pulmonary Disease 2017.

Authors:  William Z Zhang; Kazunori Gomi; Seyed Babak Mahjour; Fernando J Martinez; Renat Shaykhiev
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

Review 3.  Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC.

Authors:  Daniel Hoesterey; Nilakash Das; Wim Janssens; Russell G Buhr; Fernando J Martinez; Christopher B Cooper; Donald P Tashkin; Igor Barjaktarevic
Journal:  Respir Med       Date:  2019-08-09       Impact factor: 3.415

4.  Symptomatic smokers without COPD have physiological changes heralding the development of COPD.

Authors:  Erica Bazzan; Umberto Semenzato; Graziella Turato; Davide Biondini; Pablo Cubero; Marta Marin-Oto; Marta Forner; Mariaenrica Tinè; Alvise Casara; Simonetta Baraldo; Paolo Spagnolo; Jose M Marin; Marina Saetta; Manuel G Cosio
Journal:  ERJ Open Res       Date:  2022-06-27

5.  CT pectoralis muscle area is associated with DXA lean mass and correlates with emphysema progression in a tobacco-exposed cohort.

Authors:  Michael Emmet O'Brien; Richard H Zou; Nathan Hyre; Joseph K Leader; Carl R Fuhrman; Frank C Sciurba; Mehdi Nouraie; Jessica Bon
Journal:  Thorax       Date:  2021-12-01       Impact factor: 9.102

6.  Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.

Authors:  Suresh Garudadri; Prescott G Woodruff; MeiLan K Han; Jeffrey L Curtis; R Graham Barr; Eugene R Bleecker; Russell P Bowler; Alejandro Comellas; Christopher B Cooper; Gerard Criner; Mark T Dransfield; Nadia N Hansel; Robert Paine; Jerry A Krishnan; Stephen P Peters; Annette T Hastie; Fernando J Martinez; Wanda K O'Neal; David J Couper; Neil E Alexis; Stephanie A Christenson
Journal:  Chest       Date:  2019-01-23       Impact factor: 9.410

Review 7.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

8.  Normal Routine Spirometry Can Mask COPD/Emphysema in Symptomatic Smokers.

Authors:  Arthur F Gelb; Alfred Yamamoto; Eric K Verbeken; James C Hogg; Donald P Tashkin; Diem N T Tran; Roxanna M Moridzadeh; Christine Fraser; Mark J Schein; Marc Decramer; Eric F Glassy; Jay A Nadel
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

9.  Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.

Authors:  Giorgia Radicioni; Agathe Ceppe; Amina A Ford; Neil E Alexis; R Graham Barr; Eugene R Bleecker; Stephanie A Christenson; Christopher B Cooper; MeiLan K Han; Nadia N Hansel; Annette T Hastie; Eric A Hoffman; Richard E Kanner; Fernando J Martinez; Esin Ozkan; Robert Paine; Prescott G Woodruff; Wanda K O'Neal; Richard C Boucher; Mehmet Kesimer
Journal:  Lancet Respir Med       Date:  2021-05-28       Impact factor: 102.642

Review 10.  Impaired Respiratory Health and Life Course Transitions From Health to Chronic Lung Disease.

Authors:  Gabrielle Y Liu; Ravi Kalhan
Journal:  Chest       Date:  2021-04-15       Impact factor: 10.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.